<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03998631</url>
  </required_header>
  <id_info>
    <org_study_id>19-5219</org_study_id>
    <nct_id>NCT03998631</nct_id>
  </id_info>
  <brief_title>Comparison of Carbon Dioxide Flush and Saline Flush to Saline Flush Alone in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia</brief_title>
  <official_title>Comparison of Carbon Dioxide Flush and Saline Flush to Saline Flush Alone in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thoracic endovascular repair (TEVAR) and transcatheter aortic valve implantation (TAVI) are
      standard of care procedures to treat thoracic aortic aneurysm or severe aortic stenosis,
      respectively. Both procedures have a high risk of stroke and silent infarction. Gas has been
      detected in the cerebral vasculature during these procedures and associated with DWI positive
      lesions on MRI. Our hypothesis is that air emboli contribute to stroke and silent infarction.
      We propose addressing air emboli by flushing the device with carbon dioxide prior to flushing
      with saline. This is a pilot study comparing standard saline flush alone to carbon dioxide
      flushing with saline flush.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 15, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Infection, bleeding, stroke, pseudoaneurysm formation, etc.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Post procedural death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>7 days</time_frame>
    <description>Physical examination and magnetic resonance imaging (MRI) brain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive Decline</measure>
    <time_frame>7 days</time_frame>
    <description>Montreal cognitive assessment testing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Silent Infarction</measure>
    <time_frame>7 days</time_frame>
    <description>MRI brain.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Thoracic Aortic Aneurysm</condition>
  <condition>Aortic Stenosis Symptomatic</condition>
  <condition>Stroke, Complication</condition>
  <arm_group>
    <arm_group_label>Saline Flush</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This is the control arm. The TEVAR or TAVI device will be flushed with at least 60mL of standard saline to reduce bubbles in the reservoir prior to deployment. This is the standard of care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Carbon Dioxide and Saline Flush</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Carbon dioxide flush of the TEVAR or TAVI device followed by saline flush.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carbon Dioxide and Saline Flush</intervention_name>
    <description>The TEVAR or TAVI device will be flushed with approximately 1.2L of medical grade carbon dioxide using a 60mL syringe and connecting tubing. The reservoir will then be flushed with at least 60mL of standard saline prior to deployment to minimize bubbles in the saline.</description>
    <arm_group_label>Carbon Dioxide and Saline Flush</arm_group_label>
    <other_name>Cook Zenith alpha thoracic endovascular graft</other_name>
    <other_name>Sapien Transcatheter Heart Valve</other_name>
    <other_name>CoreValve Trascatheter Aortic Valve</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Saline Flush</intervention_name>
    <description>Standard of care flushing of the TEVAR or TAVI device with normal saline.</description>
    <arm_group_label>Saline Flush</arm_group_label>
    <other_name>Cook Zenith alpha thoracic endovascular graft</other_name>
    <other_name>Sapien Transcatheter heart valve</other_name>
    <other_name>Core Valve Transcatheter Aortic Valve</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective TEVAR or TAVI

          -  Over 18 years old

        Exclusion Criteria:

          -  Recent acute myocardial infarction

          -  Recent stroke or TIA

          -  Post or pending organ transplantation

          -  Active peptic ulcer disease

          -  Recent gastrointestinal bleed

          -  History of bleeding diathesis or coagulopathy or contraindications to antiplatelet or
             anticoagulant therapy.

          -  Permanent pacemaker or ICD

          -  History of atrial fibrillation

          -  Moderate or severe allergy to iodinated contrast not amenable to predmedication

          -  Renal failure

          -  Unable to safely undergo MRI

          -  Enrollment in another study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kong Teng Tan, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Health Network, Toronto</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kong Teng Tan, MD, FRCPC</last_name>
    <phone>416-340-4800</phone>
    <phone_ext>x6166</phone_ext>
    <email>kongteng.tan@uhn.ca</email>
  </overall_contact>
  <reference>
    <citation>Gutsche JT, Cheung AT, McGarvey ML, Moser WG, Szeto W, Carpenter JP, Fairman RM, Pochettino A, Bavaria JE. Risk factors for perioperative stroke after thoracic endovascular aortic repair. Ann Thorac Surg. 2007 Oct;84(4):1195-200; discussion 1200.</citation>
    <PMID>17888969</PMID>
  </reference>
  <reference>
    <citation>Bechara CF. Commentary: Eliminating Air From Stent-Grafts During Arch Endovascular Therapy: One Step Closer to Reducing Stroke. J Endovasc Ther. 2019 Feb;26(1):81-82. doi: 10.1177/1526602818819922. Epub 2018 Dec 21.</citation>
    <PMID>30572774</PMID>
  </reference>
  <reference>
    <citation>Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, Petrossian G, Brickman AM, Voros S, Moses J, Forrest JK. Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial). Am J Cardiol. 2016 Nov 15;118(10):1519-1526. doi: 10.1016/j.amjcard.2016.08.013. Epub 2016 Aug 23.</citation>
    <PMID>27645761</PMID>
  </reference>
  <reference>
    <citation>Perera AH, Rudarakanchana N, Monzon L, Bicknell CD, Modarai B, Kirmi O, Athanasiou T, Hamady M, Gibbs RG. Cerebral embolization, silent cerebral infarction and neurocognitive decline after thoracic endovascular aortic repair. Br J Surg. 2018 Mar;105(4):366-378. doi: 10.1002/bjs.10718. Epub 2018 Feb 12.</citation>
    <PMID>29431856</PMID>
  </reference>
  <reference>
    <citation>Rohlffs F, Tsilimparis N, Saleptsis V, Diener H, Debus ES, Kölbel T. Air Embolism During TEVAR: Carbon Dioxide Flushing Decreases the Amount of Gas Released from Thoracic Stent-Grafts During Deployment. J Endovasc Ther. 2017 Feb;24(1):84-88. doi: 10.1177/1526602816675621. Epub 2016 Oct 26.</citation>
    <PMID>27798380</PMID>
  </reference>
  <reference>
    <citation>Kölbel T, Rohlffs F, Wipper S, Carpenter SW, Debus ES, Tsilimparis N. Carbon Dioxide Flushing Technique to Prevent Cerebral Arterial Air Embolism and Stroke During TEVAR. J Endovasc Ther. 2016 Apr;23(2):393-5. doi: 10.1177/1526602816633705. Epub 2016 Feb 19.</citation>
    <PMID>26896417</PMID>
  </reference>
  <results_reference>
    <citation>Cheng D, Martin J, Shennib H, Dunning J, Muneretto C, Schueler S, Von Segesser L, Sergeant P, Turina M. Endovascular aortic repair versus open surgical repair for descending thoracic aortic disease a systematic review and meta-analysis of comparative studies. J Am Coll Cardiol. 2010 Mar 9;55(10):986-1001. doi: 10.1016/j.jacc.2009.11.047. Review.</citation>
    <PMID>20137879</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 24, 2019</study_first_submitted>
  <study_first_submitted_qc>June 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>June 24, 2019</last_update_submitted>
  <last_update_submitted_qc>June 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Health Network, Toronto</investigator_affiliation>
    <investigator_full_name>Kongteng Tan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to share data with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

